The goal of this activity is for learners to be better able to integrate Janus Kinase (JAK) inhibitors into treatment strategies for patients with moderate to severe inflammatory bowel disease (IBD).
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org
- Start Date: 2025-01-29 06:00:00
- End Date: 2025-01-29 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AbbVie (Any division) - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology
Subscribe
Login
0 Comments
Oldest